Evidence map›Paper›PMID 24509977›Full record

ArticleScientific reports2014

Molecular imprint of exposure to naturally occurring genetic variants of human cytomegalovirus on the T cell repertoire.

Corey Smith, Stephanie Gras, Rebekah M Brennan, Nicola L Bird, Sophie A Valkenburg, Kelly-Anne Twist, Jacqueline M Burrows, John J Miles, Daniel Chambers, Scott Bell and 5 more

Abstract read
In one paragraph

Article in Scientific reports, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Trial
  2. Article
  3. CD8Immunity · 2021
    Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Corey SmithQIMR Berghofer Medical Research Institute, Centre for Immunotherapy and Vaccine Development, Brisbane 4029 QLD Australia.
Stephanie GrasDepartment of Biochemistry & Molecular Biology, School of Biomedical Sciences, Monash University, Clayton 3800 VIC Australia.
Rebekah M BrennanQIMR Berghofer Medical Research Institute, Centre for Immunotherapy and Vaccine Development, Brisbane 4029 QLD Australia.
Nicola L BirdDepartment of Microbiology and Immunology, The University of Melbourne, Parkville 3010 VIC Australia.
Sophie A ValkenburgDepartment of Microbiology and Immunology, The University of Melbourne, Parkville 3010 VIC Australia.
Kelly-Anne TwistDepartment of Biochemistry & Molecular Biology, School of Biomedical Sciences, Monash University, Clayton 3800 VIC Australia.
Jacqueline M BurrowsQIMR Berghofer Medical Research Institute, Centre for Immunotherapy and Vaccine Development, Brisbane 4029 QLD Australia.
John J Miles1] QIMR Berghofer Medical Research Institute, Centre for Immunotherapy and Vaccine Development, Brisbane 4029 QLD Australia [2] Institute of Infection and Immunity, Cardiff University, School of Medicine, Heath Park, Cardiff CF14 4XN, UK.
Daniel Chambers1] Queensland Lung Transplant Service The Prince Charles Hospital, Brisbane 4032 QLD Australia [2] School of Medicine, The University of Queensland Herston 4006 QLD Australia.
Scott BellDepartment of Thoracic Medicine, The Prince Charles Hospital, Brisbane 4032 QLD Australia.
Scott CampbellRenal Transplant Unit, Princess Alexandra Hospital, Brisbane 4102 QLD Australia.
Katherine KedzierskaDepartment of Microbiology and Immunology, The University of Melbourne, Parkville 3010 VIC Australia.
Scott R BurrowsQIMR Berghofer Medical Research Institute, Centre for Immunotherapy and Vaccine Development, Brisbane 4029 QLD Australia.
Jamie Rossjohn1] Department of Biochemistry & Molecular Biology, School of Biomedical Sciences, Monash University, Clayton 3800 VIC Australia [2] Institute of Infection and Immunity, Cardiff University, School of Medicine, Heath Park, Cardiff CF14 4XN, UK.
Rajiv KhannaQIMR Berghofer Medical Research Institute, Centre for Immunotherapy and Vaccine Development, Brisbane 4029 QLD Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Exposure to naturally occurring variants of herpesviruses in clinical settings can have a dramatic impact on anti-viral immunity. Here we have evaluated the molecular imprint of variant peptide-MHC complexes on the T-cell repertoire during human cytomegalovirus (CMV) infection and demonstrate that primary co-infection with genetic variants of CMV was coincident with development of strain-specific T-cell immunity followed by emergence of cross-reactive virus-specific T-cells. Cross-reactive CMV-specific T cells exhibited a highly conserved public T cell repertoire, while T cells directed towards specific genetic variants displayed oligoclonal repertoires, unique to each individual. T cell recognition foot-print and pMHC-I structural analyses revealed that the cross-reactive T cells accommodate alterations in the pMHC complex with a broader foot-print focussing on the core of the peptide epitope. These findings provide novel molecular insight into how infection with naturally occurring genetic variants of persistent human herpesviruses imprints on the evolution of the anti-viral T-cell repertoire.

Indexed as

Antigens, ViralCD8-Positive T-LymphocytesCross ReactionsCytomegalovirusCytomegalovirus InfectionsEpitopes, T-LymphocyteGenetic VariationHeart TransplantationHLA-B8 AntigenHumansImmunologic MemoryKidney TransplantationLung TransplantationLymphocyte ActivationT-Lymphocyte SubsetsTransplantation ImmunologyAntigens, ViralEpitopes, T-LymphocyteHLA-B8 Antigen

Identifiers

PMID24509977
PMCPMC3918921

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.